Breast Cancer Clinical Trials

A listing of Breast Cancer medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

UPDATED

Birmingham Alabama 35211

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

UPDATED

Birmingham Alabama 35294

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

UPDATED

Mobile Alabama 36604

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

Arizona

UPDATED

Glendale Arizona 85304

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

UPDATED

Tucson Arizona 85724

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

UPDATED

Yuma Arizona 85364

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

Arkansas

UPDATED

Fayetteville Arkansas 72703

Patients are needed to participate in a clinical research study of LEE011, Exemestane and Everolimus to evaluate Breast Cancer

UPDATED

Little Rock Arkansas 72205

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

California

UPDATED

Additional Locations California 93901

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

UPDATED

Fountain Valley California 92708

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

UPDATED

Fullerton California 92835

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

UPDATED

Los Angeles California 90033

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

UPDATED

Sacramento California 95817

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

View More ▼

UPDATED

San Francisco California 94115

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

UPDATED

Vallejo California 94589

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

UPDATED

West Hills California 91307

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

Connecticut

UPDATED

Southington Connecticut 06489

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

Florida

UPDATED

Deerfield Beach Florida 33442

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

UPDATED

Fort Myers Florida 33916

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

UPDATED

Hollywood Florida 33021

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

UPDATED

Jacksonville Florida 32207

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

UPDATED

Miami Florida 33136

Patients are needed to participate in a clinical research study of LEE011, Exemestane and Everolimus to evaluate Breast Cancer

View More ▼

UPDATED

New Port Richey Florida 34655

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

Georgia

UPDATED

Atlanta Georgia 30322

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

UPDATED

Atlanta Georgia 30341

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

UPDATED

Atlanta Georgia 30318

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

UPDATED

Marietta Georgia 30060

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

UPDATED

Savannah Georgia 31405

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

Illinois

UPDATED

Chicago Illinois 60637

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

UPDATED

Harvey Illinois 60426

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

UPDATED

Park Ridge Illinois 60068-0736

Patients are needed to participate in a clinical research study of LEE011, Exemestane and Everolimus to evaluate Breast Cancer

UPDATED

Peoria Illinois 60615

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

UPDATED

Skokie Illinois 60076

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

View More ▼

UPDATED

Skokie Illinois 60077

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

UPDATED

Urbana Illinois 61801

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

Louisiana

UPDATED

Lafayette Louisiana 70503

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

UPDATED

Marrero Louisiana 70072

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

UPDATED

New Orleans Louisiana 70121

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

UPDATED

New Orleans Louisiana 70112

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

Maryland

UPDATED

Annapolis Maryland 21401

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

UPDATED

Baltimore Maryland 21287-0013

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

UPDATED

Baltimore Maryland 21201

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

UPDATED

Frederick Maryland 21701

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

UPDATED

Silver Spring Maryland 20902

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

Massachusetts

UPDATED

Boston Massachusetts 02118

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

UPDATED

Boston Massachusetts 02114

Patients are needed to participate in a clinical research study of LEE011, Exemestane and Everolimus to evaluate Breast Cancer

Michigan

UPDATED

Detroit Michigan 48202

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

UPDATED

Detroit Michigan 48201

Patients are needed to participate in a clinical research study of LEE011, Exemestane and Everolimus to evaluate Breast Cancer

Minnesota

UPDATED

Minneapolis Minnesota 55407

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

Missouri

UPDATED

Kansas City Missouri 64111

Patients are needed to participate in a clinical research study of LEE011, Exemestane and Everolimus to evaluate Breast Cancer